American Oncology Network, Inc.
AONC · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 4.4% | 8.4% | 19.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 8.7% | 7.8% | 6.8% | 2.6% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 1.9% | 1.1% | 0.7% | -4.3% |
| Net Income | $0 | -$0 | $0 | -$0 |
| % Margin | 0.3% | -0.2% | 0.8% | -2.2% |
| EPS Diluted | -0.003 | -0.19 | 0.038 | -1.22 |
| % Growth | 98.7% | -606.7% | 103.1% | – |
| Operating Cash Flow | $0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | $0 |